Chester County News and Community Website
EXTON, PA — Melior Pharmaceuticals announced that it completed a definitive licensing agreement with Adhera Therapeutics, Inc . (OTCPK: ATRX) for Melior’s Parkinson’s disease (PD) candidate, MLR-1019 (armesocarb).
Read More EXTON, PA — Melior Pharmaceuticals announced that it has signed a “letter of intent” with Adhera Therapeutics, Inc . (OTCPK: ATRX) for the acquisition of Melior’s Parkinson’s disease (PD) candidate, …
Read More EXTON, PA — Melior Pharmaceuticals announced that it has received clearance of its Investigational New Drug (IND) application for the clinical development of its novel, first-in-class lyn kinase activator, tolimidone, …
Read More EXTON, PA — Melior Pharmaceuticals (Melior) has been awarded a grant from the Commonwealth of Pennsylvania’s COVID-19 Vaccines, Treatments and Therapies (CV-VTT) Program, which is designed to support rapid advancement …
Read More
WEST CHESTER, PA — A Chester County biopharma company will receive more than $210,000 in grant funding to support the advancement of a treatment in response to the COVID-19 pandemic, …
Read More